SCHEMBL6171670

SCHEMBL6171670

CN1CCC(c2cnccc2C(NC=O)N2C(=O)N(c3ccc(S(=O)(=O)C(F)(F)F)cc3)C(=O)C2(C)C)CC1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 5/20 0.38
CTSS P25774 1/20 0.33
SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173685 0.88 HTR6 (0.33) IGF1R
SCHEMBL6175215 0.84 CTSS (0.34) IGF1RCTSSSCN9A
SCHEMBL6171937 0.82 IGF1R (0.41) IGF1R
SCHEMBL6173623 0.75 IGF1R (0.38) IGF1R
SCHEMBL2939829 0.75 IGF1R (0.39) IGF1R
SCHEMBL6172228 0.73 IGF1R (0.35) IGF1R
SCHEMBL2938212 0.71 IGF1R (0.40) IGF1R
SCHEMBL6174365 0.71 HTR6 (0.35)
SCHEMBL2940341 0.70 IGF1R (0.40) IGF1R
SCHEMBL2937757 0.70 IGF1R (0.59) IGF1RCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed